Cadence, a leader in the digital securitization of alternative investments, is partnering with PULSE Medical Finance to expand its offering of investment products.
Cadence is pleased to announce a strategic partnership with PULSE Medical Finance. Established in 2017, as Pharma Funding, LLC, PULSE Medical Finance is a California-based specialty financing company that buys insurance correlated receivables and cash flow from independent health service providers such as pharmacies, surgical centers, behavior health services, durable medical equipment providers, physician groups, labs, etc. The underlying payors for the receivables are typically commercial insurance companies, Medicare, and other government entities. The company advances funds to their clients on an “as needed basis” ensuring service providers have access to consistent cash flows.
PULSE utilizes a proprietary software portal to track and manage all transactions, payments and collections, with ongoing monitoring of any delinquent payments, UCC filings, and changes in background and credit checks on its clients. To reduce payment friction, clients are required to establish a Beneficial Owner Account or must deposit baseline payments into a Clearing Account managed by PULSE.
PULSE has a current portfolio of over 18 active clients. With more than $1m in the immediate pipeline, the company expects to grow rapidly over the next several months. A partnership with Cadence will give PULSE the opportunity to scale new transaction volume while providing investors on Cadence’s platform the ability to gain exposure to a high-quality portfolio of assets in a new industry.
“We are thrilled to partner with PULSE Medical Finance, an established player looking to further grow and diversify their business in a new industry for Cadence” said Charlie Lienau, Director of Capital Markets at Cadence. “Given the growth prospects, and the quality of many of the underlying payors of the receivables, Cadence expects the partnership to be beneficial, not just for PULSE, but for a growing investor base that chooses to invest through Cadence.”
“A strategic partnership with Cadence is an ideal solution for the growth pattern we are experiencing” noted Anand Narayanan, Managing Partner for PULSE, adding that “the ability for Cadence to scale alongside us will provide the flexible capital support we need at this stage in our progress. We are very pleased to be a part of their innovative platform.”
As an alternative investment platform, Cadence continues to offer accredited investors uncorrelated, high-yield investment products while providing non-dilutive growth capital to its origination partners. Cadence is excited to partner with PULSE Medical Finance to continue building an extensive network of best-in-class originators.
About PULSE Medical Finance
PULSE Medical Finance is the first financial services platform to combine a receivables funding program with revenue cycle management solutions to healthcare providers. The platform utilizes predictive analytics to provide accounts receivable funding to help clients achieve their growth objectives without adding debt or giving up equity. Based on reimbursement rates and timelines, PULSE can advance payments for receivables in real time, saving providers from having to wait for extended reimbursement cycles dictated by payers.
PULSE works directly with surgery centers, laboratories, pharmacies, physician groups, MSOs, suppliers, and diagnostic companies and collaborates with RCM companies, Management Consulting and Accounting Firms to provide analytics and funding programs to their healthcare clients.
[This archived post was released at a time when Percent was formerly known as Cadence.]